Acquisition has become a favorite tactic by contract pharma’s most prominent players, but there’s more than one path to sustained growth, especially for those seeking the scale, global presence and technical acumen the bio/pharmaceutical industry is demanding. This article reveals other sustainable strategies for CDMO growth.
To read more about sustainable strategies, click here.
